The prevalence of MCS is difficult to ascertain due to varying diagnostic criteria and recognition across regions. Studies suggest that a small percentage of the population reports symptoms consistent with MCS, but the degree of impairment varies widely among individuals. Surveys in some countries indicate that between 2% to 6% of people self-identify with chemical sensitivities.
